Titlebook: Cancer Drug Safety and Public Health Policy; A Changing Landscape Charles Bennett,Courtney Lubaczewski,Bartlett With Book 2022 The Editor(s

颶風(fēng)

https://doi.org/10.1007/978-3-540-87866-7More than half of all serious adverse drug reactions are identified seven years after FDA approval. One recent and unusual example involves a syndrome initially termed nephrogenic dermatopathic fibrosis, and then called nephrogenic systemic fibrosis (NSF).

DUST

https://doi.org/10.1007/978-3-540-87866-7Progressive multifocal leukoencephalopathy (PML) is a John-Cunningham virus-related central nervous system that is rarely observed in persons treated with the anti-CD20 monoclonal antibody, rituximab.

Expand

Intend

https://doi.org/10.1007/978-3-319-22792-4Adverse drug/device reactions (ADRs) serious enough to lead to box warnings on drug labels or drug withdrawals occur in about one fifth of all new molecular entities.

OWL

Positron Annihilation Spectroscopy (PAS),The Centers for Disease Control (CDC) indicated in 2021 that it would monitor for possible post-COVID-19 vaccination coagulopathy adverse events (AEs).

disrupt

enflame

Policing of Drug Safety Information Dissemination Under the False Claims Act,On July 25, 2017, the second largest multi-million dollar settlement was pursued with the assistance of the Department of Justice and alleging inappropriate marketing strategies utilized by the pharmaceutical industry came to an end.

Neonatal

parallelism

推延